Crossmark

Modulating versatile pathways using a cleavable PEG shell and EGFR-targeted nanoparticles to deliver CRISPR-Cas9 and docetaxel for triple-negative breast cancer inhibition

Crossref DOI link: https://doi.org/10.1007/s12272-024-01514-0

Published Online: 2024-11-01

Published Print: 2024-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Lo, Yu-Li https://orcid.org/0000-0002-6548-3280
Hong, Ci-Jheng

Wang, Chen-Shen

Yang, Ching-Ping
Funding

Funding for this research was provided by:

National Science and Technology Council (NSTC 113-2320-B-A49-032, MOST 110-2320-B-A49A-510-MY3, MOST 107-2320-B-010-015-MY3)

National Yang Ming Chiao Tung University
License Information

Text and Data Mining valid from 2024-11-01

Version of Record valid from 2024-11-01
More Information

Article History

Received: 27 January 2024

Accepted: 7 October 2024

First Online: 1 November 2024

Declarations

:

: The authors declare no conflict of interest.

Document is current

Any future updates will be listed below